发明名称 HCV NS3 RECOMBINANT ANTIGENS AND MUTANTS THEREOF FOR IMPROVED ANTIBODY DETECTION
摘要 The present disclosure relates to polypeptides, including fusions thereof, nucleic acids, vectors, host cells, immunodiagnostic reagents, kits, and immunoassays for use detecting the presence of HCV antibodies. More specifically, the present invention describes specific NS3 antigens that can be used for the detection of anti-HCV antibodies.
申请公布号 US2014272932(A1) 申请公布日期 2014.09.18
申请号 US201314139053 申请日期 2013.12.23
申请人 Abbott Laboratories 发明人 Muerhoff A. Scott;Marohnic Christopher;Birkenmeyer Larry;Prostko John;Bogdan Felisha;Gutierrez Robin
分类号 G01N33/569;C12N9/14 主分类号 G01N33/569
代理机构 代理人
主权项 1. A recombinant HCV NS3 antigen comprising a NS3 helicase sequence that comprises each of domains I, II and III of said helicase, wherein said antigen has increased immunoreactivity against HCV antibodies from test sample as compared to C33 antigen, wherein said recombinant HCV NS3 antigen comprises one or more of the characteristics selected from the group consisting of: diminished ATP-binding activity as compared to the ATP-binding activity of wild-type NS3 helicase diminished ATPase activity as compared to wild-type NS3 as compared to the ATP-binding activity of wild-type NS3 helicase, and increased redox stability as compared to the redox stability of wild-type NS3 helicase.
地址 Abbott Park IL US